Sex and gender in COVID-19 vaccines: data, policy, and communication

·               raise awareness of sex and gender dimensions in COVID-19 vaccines, and its considerations in policy decision-making, and science communication for the public

·               describe lessons from past knowledge of sex-based differences in vaccine science and policy decision-making, including use of sex-disaggregated data and gender analysis in regulatory evaluations

·               discuss current opportunities to respond to the biological differences in women and men in COVID-19 vaccine research and consequent deployment

·               explore the path to ‘do better’ in addressing the sex and gender dimensions in vaccine and pharmaceutical R&D, policy-making and science communication process